Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Topics
- (-) Critical Materials (1)
- (-) Nanotechnology (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (6)
- Artificial Intelligence (1)
- Bioenergy (1)
- Biology (1)
- Biomedical (1)
- Buildings (1)
- Chemical Sciences (4)
- Composites (1)
- Computer Science (2)
- Decarbonization (2)
- Education (1)
- Energy Storage (4)
- Environment (2)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (2)
- Isotopes (1)
- ITER (6)
- Materials (1)
- Materials Science (4)
- Microscopy (1)
- Net Zero (1)
- Neutron Science (1)
- Nuclear Energy (26)
- Partnerships (3)
- Physics (1)
- Security (2)
- Simulation (3)
- Space Exploration (1)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
ORNL scientists combined two ligands, or metal-binding molecules, to target light and heavy lanthanides simultaneously for exceptionally efficient separation.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.